{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:40:49Z","timestamp":1781606449622,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Amyotrophic lateral sclerosis (ALS) poses a significant clinical challenge due to its rapid progression and limited treatment options, often leading to deadly outcomes. Looking for effective therapeutic interventions is critical to improve patient outcomes in ALS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The patient, a 75-year-old East Asian male, manifested an insidious onset of right-hand weakness advancing with dysarthria. Comprehensive Next-generation sequencing analysis identified variants in specific genes consistent with ALS diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>ALS diagnosis is based on El Escorial diagnostic criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>This study introduces a novel therapeutic approach using artificial intelligence phenotypic response surface (AI-PRS) technology to customize personalized drug-dose combinations for ALS. The patient underwent a series of phases of AI-PRS-assisted trials, initially incorporating a 4-drug combination of Ibudilast, Riluzole, Tamoxifen, and Ropinirole. Biomarkers and regular clinical assessments, including nerve conduction velocity, F-wave, H-reflex, electromyography, and motor unit action potential, were monitored to comprehensively evaluate treatment efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Neurophysiological assessments supported the ALS diagnosis and revealed the co-presence of diabetic polyneuropathy. Hypotension during the trial necessitated an adaptation to a 2-drug combinational trial (ibudilast and riluzole). Disease progression assessment shifted exclusively to clinical tests of muscle strength, aligning with the patient\u2019s well-being.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The study raises the significance of personalized therapeutic strategies in ALS by AI-PRS. It also emphasizes the adaptability of interventions based on patient-specific responses. The encountered hypotension incident highlights the importance of attentive monitoring and personalized adjustments in treatment plans. The described therapy using AI-PRS, offering personalized drug-dose combinations technology is a potential approach in treating ALS. The promising outcomes warrant further evaluation in clinical trials for searching a personalized, more effective combinational treatment for ALS patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037401","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T01:01:50Z","timestamp":1709341310000},"page":"e37401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A new potential therapeutic approach for ALS: A case report with NGS analysis"],"prefix":"10.1097","volume":"103","author":[{"given":"Chaur-Jong","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"},{"name":"Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chih","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"},{"name":"Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"Department of Chemical and Biomolecular Engineering Henry Samueli School of Engineering at the University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Zahn","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Taipei Medical University Hospital, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ming","family":"Ho","sequence":"additional","affiliation":[{"name":"Mechanical and Aerospace Engineering Henry Samueli School of Engineering University of California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan, ROC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0815-412X","authenticated-orcid":false,"given":"Yun","family":"Yen","sequence":"additional","affiliation":[{"name":"Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan, ROC"},{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan, ROC"},{"name":"Center for Cancer Translational Research, Tzu-Chi University, Hualien, Taiwan, ROC."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis.","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group.","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.10500","article-title":"Efficient three-drug cocktail for disease induced by mutant superoxide dismutase.","volume":"53","author":"Kriz","year":"2003","journal-title":"Ann Neurol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00415-004-0481-5","article-title":"Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.","volume":"251","author":"Waibel","year":"2004","journal-title":"J Neurol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2019.12.002","article-title":"Ropinirole, a new ALS drug candidate developed using iPSCs.","volume":"41","author":"Okano","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e20423","DOI":"10.1097\/MD.0000000000020423","article-title":"Tamoxifen for amyotrophic lateral sclerosis: a randomized double-blind clinical trial.","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"105078","DOI":"10.1016\/j.phrs.2020.105078","article-title":"Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders.","volume":"160","author":"Bhat","year":"2020","journal-title":"Pharmacol Res"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1752-0509-5-88","article-title":"Systematic quantitative characterization of cellular responses induced by multiple signals.","volume":"5","author":"Al-Shyoukh","year":"2011","journal-title":"BMC Syst Biol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"14183","DOI":"10.1038\/ncomms14183","article-title":"Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time.","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"333ra","DOI":"10.1126\/scitranslmed.aac5954","article-title":"Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform.","volume":"8","author":"Zarrinpar","year":"2016","journal-title":"Sci Transl Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/nmt-2021-0042","article-title":"MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb\/III study: COMBAT-ALS study design.","volume":"11","author":"Oskarsson","year":"2021","journal-title":"Neurodegener Dis Manag"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jop.2016.0141","article-title":"The 24-hour effects of brinzolamide\/brimonidine fixed combination and timolol on intraocular pressure and ocular perfusion pressure.","volume":"33","author":"Seibold","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000329832","article-title":"Cataract surgery in a patient with amyotrophic lateral sclerosis: a case report.","volume":"2","author":"Cenk Kohen","year":"2011","journal-title":"Case Rep Ophthalmol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front Neurosci"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3233\/JAD-2010-1328","article-title":"FUS\/TLS genetic variability in sporadic frontotemporal lobar degeneration.","volume":"19","author":"Cantoni","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(10)70197-6","article-title":"Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.","volume":"9","author":"Shatunov","year":"2010","journal-title":"Lancet Neurol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1750-1172-8-104","article-title":"Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease.","volume":"8","author":"Kim","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10048-015-0453-1","article-title":"In silico analysis of SIGMAR1 variant (rs4879809) segregating in a consanguineous Pakistani family showing amyotrophic lateral sclerosis without frontotemporal lobar dementia.","volume":"16","author":"Ullah","year":"2015","journal-title":"Neurogenetics"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"40266","DOI":"10.1074\/jbc.M110.161398","article-title":"Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis.","volume":"285","author":"Chen","year":"2010","journal-title":"J Biol Chem"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","article-title":"Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.","volume":"53","author":"van Rheenen","year":"2021","journal-title":"Nat Genet"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1093\/hmg\/ddr268","article-title":"A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese.","volume":"20","author":"Iida","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2012.10.029","article-title":"ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis.","volume":"324","author":"Tetsuka","year":"2013","journal-title":"J Neurol Sci"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10072-018-3411-5","article-title":"Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis.","volume":"39","author":"Ning","year":"2018","journal-title":"Neurol Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12017-020-08634-y","article-title":"Association of single nucleotide polymorphism at rs2275294 in the ZNF512B gene with prognosis in amyotrophic lateral sclerosis.","volume":"23","author":"Jiang","year":"2021","journal-title":"Neuromolecular Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:13:16Z","timestamp":1746328396000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037401","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}